Since polycystic ovary syndrome was described in the 1930s, the diagnostic criteria have expanded and prevalence has risen, explain Tessa Copp and colleagues. But to what extent do women today benefit from their diagnosis, particularly younger women and those with milder symptoms?
No takes yet. Share an insight, caveat, or question.
Copp et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: